Sorrento Therapeutics, Inc. - Common Stock (SRNE)
$0.0005
0.0001 (16.67%)
SRNE Stock Quote Delayed 30 Minutes
The $75 Million Reason Sorrento (SRNE) Stock Is Moving Today
SRNE stock is moving this morning after soaring about 25% yesterday. The company recently declared bankruptcy after losing a lawsuit.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
32,479
Day's Range
$0.0005 - $0.0006
52-Week Range
$0.0001 - $0.09
Dividend & Yield
N/A (N/A)
SRNE Stock Predictions, Articles, and Sorrento Therapeutics, Inc. - Common Stock News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the week with a breakdown of the biggest pre-market stock movers traders will want to keep a watch on Monday!
Sorrento Therapeutics (SRNE) Pops on FDA Fast Track Designation
Sorrento Therapeutics (SRNE) stock is getting a boost on Wednesday after the FDA granted fast-track designation for SP-103.
10 Stocks to Sell Before They Die
As the U.S. continues to struggle with stagflation, it’s becoming more important than ever to avoid pitfalls.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back, trader! We're starting off another busy week with a look at the biggest pre-market stock movers for Monday!
Dear SRNE Stock Fans, Here’s the Latest Patent News to Watch
Despite some relatively bullish news that came out yesterday, investors in vaccine stocks such as SRNE stock are in sell mode today.
Midday Market Update: What Are the Top Performing Stocks Today?
We're over halfway through the day and that means it's time to check in on what the top-performing stocks are doing on Wednesday.
7 Meme Stocks to Avoid So You Don’t Get Caught Holding the Bag
Meme stocks continue to be a thing, despite confounding analysts who are questioning whether they can survive on Reddit steam alone.
SRNE Stock: The Big News Lifting Sorrento Therapeutics Today
Today, SRNE stock is on the move in a big way as investors price in two key announcements made by the company regarding clinical trials.
The Dip Is an Opportunity in Sorrento Therapeutics Stock
The pullback in SRNE stock has cleared 40%. Sorrento has too many ways to win for the stock to stay down forever.
Sorrento Therapeutics Is Betting On A Longer Play, So Should You
The delay of Sorrento Therapeutics’ Covid-19 vaccine has weakened SRNE stock, but the company has plenty more in the pipeline.
Sorrento Stock Is Little More Than a Day Trade Now
Nearly a third of SRNE stock's float has been sold short. This sets up a catalyst for a short-term move, but avoid a long-term investment.
Government and Institutional Support Are Positives for Sorrento Stock
Sorrento just received a grant of up to $34 million from Washington, while multiple institutions own meaningful amounts of SRNE stock.
